Navigation Links
Cabinet Clears Purchase Preference Policy for Pharma PSUs

The Government today said the central departments, public sector undertakings and autonomous bodies will give first preference to central pharma PSUs like IDPL// and their subsidiaries for purchasing 102 medicines for a period of five years.

As per a decision of the Cabinet, which met here today, the first preference will also be given to these pharma PSUs and their subsidiaries by state governments in their purchases which are funded by the Centre.

The purchasing departments may invite limited tenders from pharma PSUs and their subsidiaries or purchase directly from them at notified price with a discount up to 35 per cent, Information and Broadcasting Minister P R Dasmunsi told reporters after the Cabinet meeting.

If no pharma CPSE is forthcoming to supply these medicines, the purchasing departments would be at liberty to buy from other manufacturers, I& B Minister P R Dasmunsi said.

The purchasing departmens would purchase from these PSUs, and their subsidiaries, subject to their meeting Good Manufacturing Practices norms.

The purpose of the Purchase Preference Policy is to make available quality drugs under various health schemes and help in optimum utilisation of assets of these public sector units, Dasmunsi said.

The size of pharma market in the country stands at Rs 50,000 crore, including exports of around Rs 17,000 crore. Of this, central departments purchase around Rs 2,000 crore of medicines and state governments account for another Rs 1,500-2,000 crore per annum for their health programmes.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Business model for Liver Institute cleared by Delhi Cabinet
2. Baby Acne Clears Up On Its Own
3. SC Clears Deck For Implementation Of Nutrition Scheme
4. Bangkoks Public Health Ministry Clears The Northern Province Of Bird Flu Epidemic
5. European Commission Clears Diabetic Insulin for Pregnant Women
6. Delhi Government Clears Healthcare Projects Worth Rs.1.13 bn
7. FDA Clears Breast Cancer Specific Molecular Prognostic Test
8. FDA Clears Critical Limb-Saving Vascular Device
9. The Risks Involved In Purchase Of Over The Counter Medications
10. Online Auction Results In Purchase of Chemicals
11. Aurobindo Pharma Purchases US Manufacturing Facility
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
Breaking Medicine Technology: